Skip to content

Not medical advice. Talk to your provider before using any peptide. Full disclaimer

Peptide Schedule Research TeamReviewed Apr 7, 202622 Citations

Tesamorelin peptide icon, one bubble per amino acidTesamorelin44 residuesYADAIFTNSYRKVLGQLSARKLLQDIMSRQQGESNQERGARARLEach bubble = one amino acid. Size = residue mass. Color = chemical class.

Tesamorelin Dosage Calculator

Growth Hormone · FDA Approved · Grade A · 8-11 min half-life · Injection

Calculate your dose

Adjust vial, water and dose. The answer updates live.

mL
Dose
Syringe

All three take the same units for the same dose. A smaller barrel just spreads it over more space.

↓ 35.0020406080100
Draw to 35.0 units= 0.350 mL

on a U-100 syringe for a 1,400 mcg = 1.4 mg dose

Check that your syringe says U-100.

Concentration
4,000
mcg/mL
Doses / vial
1
Your mixing recipe

Mix your 2 mg vial with 0.5 mL of the diluent its directions name. Draw to 35.0 units on a U-100 syringe for a 1.4 mg dose. This vial will last 1 dose.

A reminder for 1.4 mg (35 units) every day, with a free account.

Dose math and a schedule you can keep.

Syringe units in one tap. A free account adds dose reminders and calendar sync, plus alerts on the peptides you save.

Track every dose with reminders and a calendar.

  • Dose remindersPush or calendar alarm
  • Peptide alertsFor peptides you save
  • Calendar syncApple, Google, Outlook
  • Supply countsDoses left per vial

Your plans, logs and saved peptides sync to every device.

Opens a preview of your schedule first.

Your logs and saved lists are never sold, and not shared except where you choose.

What you need to mix this6 items, matched to your vial, diluent and syringe
  • Tesamorelin, 2 mg vialThe vial size set in the calculator.
  • Diluent, 0.5 mLEGRIFTA SV: only the Sterile Water for Injection in its kit, not bacteriostatic water. EGRIFTA WR and compounded vials: the diluent their directions or pharmacy name.
  • 1 mL U-100 insulin syringe (100 units)Matches the syringe set in the calculator. Use a new sterile one for every injection.
  • Alcohol swabsFor each vial stopper every time a needle goes in, and for the injection site. Let the alcohol dry first.
  • A sharps containerUsed syringes go in right after each injection, never loose in the trash.
  • Storage after mixingEGRIFTA SV: inject right after mixing and discard any unused solution; do not refrigerate or freeze it. EGRIFTA WR: keep the mixed vial at 20-25°C and discard it 7 days after mixing. Compounded vials: refrigerate at 2-8°C, use within 14 days.

How to choose each item: the peptide supplies guide.

Open Tesamorelin details
Side effects, protocols by goal, storage, and the sources behind these dosing numbers.

About Tesamorelin

Turns your vial size, diluent, and dose into exact syringe units. Free to use.

Tesamorelin is the only FDA-approved GHRH analog for visceral fat reduction, backed by Phase 3 data in 816 patients. Originally indicated for HIV lipodystrophy, it's now widely used off-label for belly fat and GH optimization. The catch is that visceral fat returned within six months of stopping in the trials.

FDA-ApprovedGHRH AnalogVisceral FatLipodystrophyLiver Health
Hunter Williams
Used by Williams
Subcutaneous. Typical beginner frequency: daily.At beginner dose (1400 mcg) with a 2mg/0.5mL vial: draw to the 35-unit mark on a U-100 syringe.
After reconstituting, store at 2-8°C (36-46°F) for compounded vials; EGRIFTA WR at 20-25°C (68-77°F) for up to 7 days; EGRIFTA SV is not stored after mixing. EGRIFTA SV: inject right after mixing and discard any unused solution; do not refrigerate or freeze it. EGRIFTA WR: keep the mixed vial at 20-25°C and discard it 7 days after mixing. Compounded vials: refrigerate at 2-8°C, use within 14 days.

View side effects and safety warnings →

Quick-Start: Reconstitution

  1. 1Gather your supplies. You'll need a 2 mg tesamorelin vial (lyophilized powder), 0.5 mL of diluent, a mixing syringe with an 18-gauge needle for reconstitution, and a U-100 insulin syringe (29 to 31 gauge, half-inch needle) for injection. EGRIFTA SV comes with its own diluent, and its label says to use only that one. Do not use bacteriostatic water with EGRIFTA SV. For a compounded vial, use the diluent your pharmacy names.
  2. 2Reconstitute the vial. Draw 0.5 mL of diluent into the mixing syringe. Inject slowly down the inside wall of the vial. Do not shake; roll the vial gently between your hands until the powder dissolves. This gives you 4 mg/mL. The solution should be clear and colorless; discard if cloudy or discolored.
  3. 3Draw your dose. Using a fresh U-100 insulin syringe, draw 35 units (0.35 mL) for the 1.4 mg EGRIFTA SV label dose. The 2 mg Phase 3 trial dose most community protocols use is 50 units (0.5 mL, the whole vial).
Full injection guide →

Tesamorelin Dosing Protocol

FDA LabelEGRIFTA SV (tesamorelin) FDA Prescribing Information (2026): 1.4 mg once daily (n=816 (two Phase 3 trials))
LevelDose / InjectionFrequency
Beginner1.4 mgDaily
Moderate1.4 mgDaily
Aggressive1.4 mgDaily
Note:

With a 5 mg vial and 2 mL bacteriostatic water, you get 2.5 mg/mL (2500 mcg/mL). At that concentration: 2000 mcg (the 2 mg Phase 3 trial dose most community protocols use) is 80 units on a U-100 insulin syringe. That's 0.8 mL, so you'll use close to half the syringe. Each 5 mg vial gives you 2.5 daily doses at 2 mg per day. The EGRIFTA SV label dose is lower: 1.4 mg (0.35 mL of its own reconstituted 2 mg vial) once daily.

With the 2 mg vial (EGRIFTA SV) and 0.5 mL of diluent, you get 4 mg/mL: 1.4 mg is 35 units (0.35 mL), and a 2 mg dose is the whole vial, 50 units (0.5 mL). Each 2 mg vial makes one dose.

Inject into abdominal subcutaneous fat only. The FDA label specifies this, and the clinical data was collected this way. Don't rotate to thigh or arm. Rotate within the abdomen, at least 2 cm from the umbilicus.

The non-obvious thing: your IGF-1 check at four to six weeks isn't optional. If IGF-1 hasn't risen, either the peptide is degraded, your injection technique is off, or you've drawn a bad batch from the compounder. Don't run a full 26-week cycle without confirming the molecule is actually working.

Pre-bed injection is the community preference for off-label use because it matches the natural nocturnal GH surge. FDA trials used morning dosing. Either works; consistency matters more than timing.

Dosing based on EGRIFTA SV (tesamorelin) FDA Prescribing Information (2026): 1.4 mg once daily: 22 published references.View all sources →

How the Tesamorelin Math Works

2mg in 0.5mL
=4mg/mL
4mg/mL
=40 mcg per unit
1,400 mcg / 40
=35 units
2mg / 1,400 mcg
=1 dose

Based on a 2mg vial, 0.5mL of the diluent its directions name, the beginner dose (1,400 mcg), and a U-100 syringe. Change any input in the calculator and every line moves with it.

Ask AI about this math

Cross-check your Tesamorelin reconstitution math with AI

Tesamorelin Cost

Brand Price
Egrifta SV: ~$3,085/month (typical US cash price without insurance, 2026); Egrifta WR: ~$41,000/year list price. Patient assistance programs exist for qualifying patients.
Generic / Research
No FDA-approved generic tesamorelin as of October 2026 (Drugs@FDA)
Compounded
$150–$300/month from US telehealth/compounding pharmacy providers; some programs from ~$50/week with included medical supervision

Pricing updated 2026-04-09

Prices are estimates and vary by source, location, and prescription status.Full pricing breakdown →

Tesamorelin Pharmacokinetics

Pharmacokinetics: Active Dose Over Time

t½ = 8-11 min (single SC dose, EGRIFTA SV and WR labels)
50%25%12.5%100%75%50%25%0%010m19m29m38m48mTime after injectionDose remaining
After 1 half-life (10m): 50% remainsAfter 2 half-lives (19m): 25% remainsAfter 3 half-lives (29m): 12.5% remains
At a 1.4 mg dose: 50% = 700 mcg remaining after 10m. Moderate-tier frequency in our sources: Daily.

Disclaimer: This curve is a simplified first-order exponential decay model. Actual pharmacokinetics vary based on injection site, individual metabolism, body composition, and other factors. Half-life values are approximate and based on available preclinical and clinical literature. Many research peptides lack formal human pharmacokinetic studies. This is for educational purposes only, not medical advice.

Read the full Tesamorelin guide →Best Peptides for Muscle Growth →

Comparing Options?

Related Tools

Frequently Asked Questions

It depends on your vial size, the diluent volume, and dose. For a 2mg vial with 0.5mL of the diluent its directions name, a beginner dose of 1400mcg is typically 35 units on a U-100 syringe. Use the calculator above for your exact numbers.

For EGRIFTA SV, use the diluent its directions name, not standard bacteriostatic water. The standard amount is 0.5mL for a 2mg vial. More liquid gives a more dilute solution, so the same dose fills more of the syringe and is easier to measure. Less liquid makes the draw smaller and harder to read. The number of doses per vial does not change either way, since that depends only on vial size and dose. Adjust the diluent amount in the calculator to see how it changes your syringe units. EGRIFTA WR is a separate kit. Its 11.6 mg vial is mixed with 1.3 mL of the supplied bacteriostatic water for 8 mg/mL, and each 1.28 mg daily dose is 0.16 mL (EGRIFTA WR label, section 2.2). Vial math does not give those numbers, so the calculator is set up for EGRIFTA SV.

At a beginner dose of 1400mcg daily, a 2mg vial lasts about 1 dose. The calculator shows exact doses per vial for your selected tier.

Most people use a 1mL U-100 insulin syringe (100 units). For very small doses, a 0.5mL or 0.3mL barrel is easier to read. All three are U-100 graduated, so the number of units to draw is the same on each. Veterinary U-40 syringes are a different scale and the calculator adjusts for that separately.

Store reconstituted Tesamorelin at 2-8°C (36-46°F) for compounded vials; EGRIFTA WR at 20-25°C (68-77°F) for up to 7 days; EGRIFTA SV is not stored after mixing. EGRIFTA SV: inject right after mixing and discard any unused solution; do not refrigerate or freeze it. EGRIFTA WR: keep the mixed vial at 20-25°C and discard it 7 days after mixing. Compounded vials: refrigerate at 2-8°C, use within 14 days. Unopened vials: EGRIFTA SV and EGRIFTA WR: store at room temperature, 20-25°C (68-77°F), in the original box to protect from light; excursions to 15-30°C are permitted.